How to Invest in Sunway Healthcare in Malaysia 2026

Why Invest in Sunway Healthcare IPO in Malaysia?

The Sunway Healthcare (KLSE: SUNMED, Stock Code: 5555) IPO is set to be the largest IPO listing on Bursa Malaysia in 2026. Sunway Healthcare (Sunway Medical)  is backed by the trusted Sunway Group. This projected RM16 billion IPO valuation is a rare high-conviction play. With a 42% profit surge in 2024 and a commitment to a 30% dividend payout, it offers the perfect blend of capital growth and steady passive income for your portfolio.

According to Securities Commission Malaysia, the Sunway Healthcare IPO is officially open for subscription from February 27 to March 5, 2026. As the most significant Bursa IPO in over a decade, this is a limited-time opportunity to secure a stake in a premier RM16 billion healthcare leader.

With the KLSE (Bursa Malaysia) hitting an eight-year high recently and several new IPOs delivering stellar first-day gains, investor sentiment is at a peak. Malaysian investors should take advantage of the Sunway Healthcare IPO. Here are the top benefits of Sunway Healthcare IPO:

• The Year’s Largest IPO: Set to be the largest IPO of 2026, Sunway Healthcare is valued at an estimated RM16 billion. It represents the largest healthcare listing in Bursa Malaysia in over a decade, attracting significant institutional and retail interest.

• Attractive Dividend Policy: Understanding the Malaysian investor’s preference for passive income, Sunway Healthcare has committed to a dividend payout ratio of up to 30% of its net profit, offering a blend of capital growth and consistent yields.

• Shariah-Compliant Investment: The IPO is officially Shariah-compliant, making it accessible to a wider range of Islamic funds and retail investors seeking ethical, high-quality assets.

• Proven Sunway Group Pedigree: Sunway Healthcare is a key subsidiary of the Sunway Group, a conglomerate with a sterling reputation. All three currently listed Sunway entities are known for solid fundamentals, consistent earnings growth, and steady stock price appreciation, making their fourth spin-off a high-conviction play.

• World-Class Healthcare Infrastructure: Its flagship, Sunway Medical Centre, is Malaysia’s largest quaternary private hospital. It has earned global recognition by being ranked in "World's Best Hospitals 2024 & 2025", underscoring its clinical excellence and regional leadership.

Who is Sunway Healthcare?

Sunway Healthcare is a leading integrated private healthcare provider in Malaysia and a core pillar of the renowned Sunway Group. Since Sunway Healthcare (Sunway Medical) launched its flagship Sunway Medical Centre in 1999, the Group has built a premier ecosystem of tertiary hospitals and ambulatory care centres known for clinical excellence.

A key differentiator is its international standing; it was the first in Southeast Asia to be accredited by the Australian Council on Healthcare Standards (ACHS). With specialized centres in oncology and robotic surgery, Sunway Healthcare is a major player in regional medical tourism. Backed by a strategic partnership with GIC, Singapore’s sovereign wealth fund, the Group is well-capitalized for expansion. For those eyeing the Sunway Healthcare IPO, these factors define Sunway Healthcare as a high-quality, institutional-grade asset with a proven track record of meeting Malaysia's rising healthcare demands.

Why Consider Investing in Sunway Healthcare IPO with Moomoo Malaysia?

When it comes to high-profile listings like the Sunway Healthcare IPO, your platform choice can significantly impact your potential returns and overall experience. Moomoo Bursa IPO features an easy IPO solution that removes barriers for retail investors, enabling you to participate in this milestone healthcare listing with confidence and efficiency.

1. No Fees for IPO Subscription: Maximize Sunway Healthcare IPO Investment

Participating in the Sunway Healthcare IPO through Moomoo Malaysia eliminates these barriers by offering 0 fees for IPO subscriptions and RM0 CDS account fees. This transparent pricing ensures every Ringgit is directed toward securing shares in a leading healthcare group. By removing upfront costs, Moomoo Malaysia provides a significant advantage, allowing local investors to focus purely on the growth potential of this institutional-grade listing on Bursa Malaysia. For more information on Moomoo Malaysia fees, refer to Moomoo Pricing.

2. 4x IPO Leverage Financing: Boost Your Sunway Healthcare Allocation

In high-demand listings such as the Sunway Healthcare IPO, retail oversubscription is common, resulting in small individual allotments. Moomoo Malaysia addresses this by offering up to 4x leverage financing, allowing Malaysian investors to significantly boost their subscription amount.

By leveraging their capital, investors can apply for a larger volume of shares than their cash balance would typically allow, thereby increasing their chances of receiving a higher allotment in this premier healthcare group. This financial flexibility is essential for those looking to build a substantial position in Bursa Malaysia’s most anticipated healthcare IPO of the year. Here are the steps for accessing IPO financing on Moomoo Malaysia:

IPO Financing Comparison: Moomoo vs. Others

Securing a significant allotment in a high-demand listing like the Sunway Healthcare IPO often requires higher buying power. While several platforms operate in Malaysia, Moomoo Malaysia currently offers the most reliable and accessible 4x IPO leverage for this landmark event.

To help you choose the right platform, here is how Moomoo compares to other popular brokers in Malaysia:

• Webull Malaysia: While Webull is a popular choice for global trading, it does not currently support Bursa Malaysia IPO subscriptions, making it unavailable for those looking to apply for Sunway Healthcare.

• M+ Global (Mplus): Although Mplus traditionally supports 4x IPO leverage, its financing pool for major listings is often limited. Due to the massive demand for Sunway Healthcare, their financing quota is currently full, meaning investors can no longer access leverage through their platform for this specific IPO.

With other platforms facing quota limits or lacking IPO support entirely, Moomoo Malaysia remains the premier gateway to boost your chances for a higher allotment.

3. Moomoo Conditional Orders: Automate Your Trading Strategy

The listing day of a major Bursa IPO, such as Sunway Healthcare, often brings rapid price swings. Moomoo’s Conditional Orders help you manage this volatility by allowing you to pre-set automated "Sell" or "Buy" triggers before the market opens. Whether investors want to lock in a target profit or set a Stop-Loss to protect their capital, the system executes their plan instantly—even if they aren't monitoring the screen. This ensures you trade Sunway Healthcare shares with institutional-grade discipline and zero emotional bias.

Example of Applying Conditional Orders for IPO

Imagine the Sunway Healthcare IPO price is RM1.50. On listing day, you are busy at work and cannot monitor the screen.

• The Strategy: You set a Stop-Loss Conditional Order at RM1.40.

• The Outcome: If the Sunway Healthcare price suddenly dips, Moomoo's system triggers an instant sell at RM1.40, capping your loss. Conversely, you could set a Take-Profit at RM2.00 to automatically lock in a 33% gain the moment the Sunway IPO price hits your target.

Whether the market goes up or down, your plan for Sunway Healthcare IPO executes perfectly without you lifting a finger.

Here are the steps to find Moomoo's conditional order feature:

4. 0 Interest if No Allotment: Risk-Free Buying Power

Moomoo Malaysia addresses this by offering 0 interest if no allotment. This allows investors to leverage their positions in the Sunway Healthcare IPO and boost their buying power through IPO financing, without the risk of interest expenses being wasted. If an investor is unsuccessful in the ballot, they pay nothing in interest. This protection is a game-changer for the Sunway Healthcare IPO, enabling local investors to bid more aggressively for this high-demand healthcare stock while keeping their capital secure.

5. Direct IPO Access: A Seamless One-Stop Solution

Moomoo Malaysia simplifies access to IPOs by providing direct access, offering a seamless, one-stop solution for the entire Sunway Healthcare IPO subscription process. From reviewing the prospectus to submitting an application and checking allotment results, every step is integrated within a single, user-friendly interface. This streamlined approach saves Malaysian investors time and reduces the risk of missed deadlines, making participation in Bursa Malaysia's premier healthcare listing more accessible than ever.

6. 24/7 Market Insights: Stay Ahead of the Sunway Healthcare IPO

Moomoo Malaysia provides 24/7 Market Insights and real-time news on the Sunway Healthcare IPO, ensuring investors never miss critical updates on the prospectus, pricing, or allotment dates. Beyond news, Moomoo offers exclusive access to expert analysis and potentially live sessions with IPO executives. For Malaysian investors, this means moving beyond guesswork to data-driven decisions. By providing professional-grade tools and expert assistance, Moomoo Malaysia empowers users to navigate the Bursa Malaysia landscape with the confidence of an institutional player.

7. Maximize Your Gains: Moomoo Exclusive IPO Season Promotions

With the Sunway Healthcare IPO application window active from February 27 to March 5, 2026, there has never been a better time to move your capital to Moomoo. Beyond the IPO itself, Moomoo Malaysia offers high-value rewards that ensure your money works harder for you before, during, and after the listing.

• Boost Your Yield with Moomoo Cash Plus (Up to 6% p.a.): By depositing into Moomoo Cash Plus, you can earn approximately 6%* p.a. in returns before or after the Sunway Healthcare IPO. These funds remain instantly deployable for your IPO subscription, ensuring you maximize interest gains without missing the perfect investment window on Bursa Malaysia.

• Claim Exclusive New User Rewards: By registering and depositing, you can participate in Moomoo’s latest welcome campaigns. Whether it’s free stocks, cash vouchers, or bundle rewards, investors can secure these bonuses now while apply IPO subscription.

• Asset Transfer Bonus: Earn Guaranteed Gold: For seasoned investors, Moomoo offers a premium Stock Transfer-In promotion. By moving your existing portfolio from other brokers to Moomoo Malaysia, you can qualify for rewards such as physical gold bars or gold vouchers.

How to Apply Sunway Healthcare IPO for Malaysian Investors

Applying for the Sunway Healthcare IPO is a straightforward process when using a digital-first platform like Moomoo Malaysia. By following the official timeline and eligibility criteria set by Bursa Malaysia, local investors can secure their stake in this leading healthcare group with just a few taps.

1. Pre-application Preparation

Determine Eligibility: The IPO is open to Malaysian citizens (18+), local corporations, and institutional investors. Applicants must possess a valid CDS account and a Malaysian correspondence address. Note that you may only submit one application per category, with a minimum subscription of 100 shares (or multiples of 100).

Know the Application Timeline: Timely submission is critical. While specific dates will be finalized in the Sunway Healthcare prospectus, applications typically open at 10:00 AM on the launch date, 27th Feb 2026, and close at 5:00 PM on the closing date, 5th March 2026. Always check the Bursa Securities website for official announcements.

2. Subscribe to Sunway Healthcare IPO with Moomoo Malaysia

Moomoo Malaysia offers a seamless, paperless experience for retail investors. Here is the 3-step process to get started:

Step 1: Sign up and Open a CDS Account

Download the Moomoo app and complete your registration. You can open a CDS Account-IPO directly through the platform to enable electronic subscriptions.

Step 2: Access the IPO Portal

Navigate to the 'Markets' tab, select 'MY', and click on 'IPO'. Here, you will find the Sunway Healthcare IPO listing along with its prospectus and key details.

Step 3: Submit & Await Allotment

Enter your desired share quantity, choose your financing option (up to 4x leverage), and submit. You can track your application status and allotment results directly within the app.

3. Post-Application: Understanding Your IPO Results

Once the balloting process for the Sunway Healthcare IPO is complete, Bursa Malaysia will announce the results. Whether your application is successful or not, the processing of your funds and shares is automated for your convenience.

Successful Applicants

If you are successfully allotted shares, they will be credited directly into your CDS account. A formal notice of allotment will be issued before the official listing date on the Main Market. These shares are held digitally with the Bursa Depository, allowing you to start trading Sunway Healthcare shares immediately upon market opening on the listing day.

Unsuccessful or Partially Successful Applicants

If your application for the Sunway Healthcare IPO is unsuccessful or only partially successful, your subscription fund (or the surplus balance) will be refunded within 10 Market Days. For those using Moomoo Malaysia, the refund process is seamless; funds are typically credited back to your account electronically, eliminating the need to wait for physical banker's drafts or mail.

Utilization of Sunway Healthcare IPO Proceeds

The Sunway Healthcare (Sunway Medical) IPO marks a historic milestone for Bursa Malaysia, representing a major spin-off from the Sunway Group. As one of the most anticipated listings in recent years, this IPO provides investors with a direct gateway into a high-growth, institutional-grade healthcare provider with a massive expansion roadmap.

The capital raised from the Sunway Healthcare IPO is earmarked to fund a multi-year growth plan to solidify its market leadership in Southeast Asia. A significant portion of the proceeds will be utilized for capital expenditure (CAPEX) to fund the development and expansion of its hospital network.

Expansion of Hospital Network & Bed Capacity

A primary driver for the Sunway Healthcare IPO is aggressive clinical expansion. The Group aims to double its capacity to over 3,400 beds by 2032 by funding new hospitals like Sunway Medical Centre, Damansara, and Ipoh. These strategic projects target high-demand urban markets, further solidifying the Group's leadership on Bursa Malaysia.

Investment in Advanced Medical Technology

Sunway Healthcare will allocate the proceeds from the IPO to state-of-the-art medical equipment, including robotic-assisted surgery and advanced oncology tools. Upgrading its technological suite aims to attract top medical talent and high-margin complex cases, strengthening its appeal to international medical tourists and boosting long-term profitability on Bursa Malaysia.

Digital Transformation & Operational Efficiency

Proceeds from the Sunway Healthcare IPO will enhance digital infrastructure, including AI-driven management and integrated Electronic Medical Records. These investments streamline workflows and use data analytics to improve clinical outcomes and reduce costs. For investors on Bursa Malaysia, this digital shift drives long-term operational efficiency and shareholder value.

Debt Repayment & Working Capital

Sunway Healthcare intends to use the capital to optimize its capital structure by repaying existing bank borrowings. Reducing debt will lower interest expenses and strengthen the Group's balance sheet, providing the financial flexibility needed to sustain dividend payments and fund future strategic acquisitions. The remaining funds will serve as general working capital to support the day-to-day operations of its expanding network of hospitals and ambulatory care centres.

Sunway Healthcare: Company Financial Performance

By combining high growth with the stability of the Sunway brand, the Sunway Healthcare (Sunway Medical) IPO offers a rare balance of capital appreciation potential and defensive security. Sunway Healthcare IPO is considered a "blue-chip" opportunity for Malaysian investors. The company has moved past the heavy gestation periods of its newer hospitals and is now entering a phase of high-margin profitability.

Here are the key financial pillars that make this IPO stand out:

• Robust Revenue and Profit Growth: In the 2024 financial year, Sunway Healthcare reported a massive 42% surge in net profit to RM257.5 million. This was supported by a 27% increase in revenue to RM 1.85 billion. For investors, these figures signify a company that isn't just growing its top line but is becoming significantly more efficient at converting sales into actual profit.

• Diverse Revenue Streams: Unlike smaller healthcare players, Sunway Healthcare benefits from a diversified portfolio. While its flagship Sunway Medical Centre in Sunway City remains a dominant cash cow, its newer hospitals in Penang and Kelana Jaya have scaled rapidly. This reduces "single-location risk" and ensures that as one facility matures, another is ready to drive the next wave of growth.

• Strong Institutional Backing: A major vote of confidence comes from GIC, Singapore’s sovereign wealth fund, which holds a strategic stake in the group. GIC’s involvement ensures institutional-grade financial discipline and provides a valuation benchmark that many retail investors look for when assessing the stability of a new listing.

• Resilience and Defensive Nature: The Malaysian healthcare sector is historically defensive. Regardless of economic cycles, healthcare remains a necessity. Sunway Healthcare’s ability to maintain high bed occupancy rates and attract international medical tourists provides a buffer against market volatility, making it an ideal long-term core holding for a Malaysian portfolio.

Sunway Group: The Proven Powerhouse Behind Sunway Healthcare

Investing in the Sunway Healthcare IPO means backing a subsidiary of Sunway Group, one of Malaysia’s most respected and financially sound conglomerates. For Malaysian investors, the "Sunway" brand is synonymous with stable fundamentals, consistent capital appreciation, and reliable dividend payouts.

A Proven Ecosystem of Market Leaders

Sunway Healthcare follows in the successful footsteps of its listed siblings in Bursa Malaysia:

• Sunway Berhad (KLSE: 5211): The parent company is known for massive township developments and a diversified, resilient business model.

• Sunway Construction (KLSE: 5263): A leader in national infrastructure, recently rewarding shareholders with a massive 41.50 sen total dividend in FY2025.

• Sunway REIT (KLSE: 5176): One of Malaysia’s largest REITs, consistently distributing 90%–100% of its income to investors.

Exclusive 1-for-10 Reward: Sunway Group's Gift to Shareholders

Existing Sunway Berhad shareholders will receive 1 Sunway Healthcare share for every 10 Sunway Berhad shares held. This move adds immediate value to your portfolio and proves the Group’s commitment to sharing its healthcare success directly with its investors.

Why Sunway Healthcare is the "Next Big Winner"

Just like its parent and sister companies, Sunway Healthcare is built for long-term passive income.

• High Payout Ratio: Sunway Healthcare has committed to a 30% dividend payout ratio, appealing directly to Malaysia’s income-seeking investors.

• Synergy & Growth: As the Group's healthcare arm, it benefits from the massive footfall and ecosystem of Sunway City and other integrated townships, ensuring a steady stream of patients and robust revenue.

By subscribing to the Sunway Healthcare IPO, you are not just buying into a hospital; you are joining a proven ecosystem designed to generate wealth.

FAQs

Is Sunway Healthcare Share Shariah Compliant?

According to the Sunway Healthcare Holdings Berhad prospectus, the shares have been classified as Shariah-compliant by the Shariah Advisory Council (SAC) of the Securities Commission Malaysia. This classification is based on rigorous screening of the Group’s core business activities and financial ratios, ensuring compliance with Islamic ethical standards.

The Group has also demonstrated its commitment to Islamic finance principles by lodging a RM5 billion Sukuk Wakalah programme to fund its hospital expansions and working capital. This Shariah-compliant status remains valid from the date of the prospectus issue until the next review by the SAC.

What is the Bursa Malaysia IPO Process?

The Bursa Malaysia IPO process involves five critical stages: Opening (applications begin at the fixed retail price), Closing (the final deadline to submit your bid), Balloting (a random selection process for oversubscribed shares), Allotment (successful shares are credited to your CDS account), and Listing (the official trading debut on the Main Market). Follow each stage on Moomoo Malaysia to stay ahead.

What are the Advantages for Existing Sunway Berhad Shareholders Invest via Moomoo?

As an existing Sunway Berhad shareholder, you are likely entitled to Sunway Healthcare shares via the upcoming dividend-in-specie. However, simply waiting for your distribution is a missed opportunity. By consolidating your portfolio on Moomoo Malaysia, you can turn this passive event into a high-yield strategy.

• Exclusive Transfer-In Rewards: High-net-worth investors can earn limited-edition gold rewards (up to 10g) or premium cash vouchers by moving their Sunway holdings to Moomoo.

• 6%* p.a. Return on Idle Cash: You can park your funds in Moomoo Cash Plus to enjoy a promotional 6%* p.a. return, ensuring your capital works for you immediately.

• Boost Your Stake: Use up to 4x IPO leverage for other Bursa Malaysia IPO stocks, just like Sunway Healthcare. This allows you to bid more aggressively for additional retail shares beyond your preferential allocation, maximizing your total exposure.

• Build Your Investment Portfolio: Deposit now and start trading immediately. You can use your buying power to invest in high-growth US stocks or established Bursa Malaysia stocks, allowing you to grow your investment portfolio.

Conclusion

The Sunway Healthcare IPO is Malaysia's most anticipated listing, valued at RM16 billion. Offering a rare blend of defensive stability and high growth, the Group reported a 42% profit surge in 2024 and plans to double bed capacity by 2032. Investors can benefit from a 30% dividend payout, Shariah-compliant status, and global medical prestige. This institutional-grade asset is a cornerstone opportunity for any Bursa Malaysia portfolio seeking long-term resilience and capital appreciation.

Moomoo's fee-free IPO application, 4x leverage, conditional order feature, and perks like exclusive insights ensure streamlined participation in every Bursa Malaysia IPO. By preparing ahead of the expected 2026 prospectus launch, register and deposit with Moomoo Malaysia to secure your position to benefit from the Bursa IPO.

Disclaimer

This article is carefully compiled based on the public exposure of the prospectus. It aims to provide readers with an overview of the basic information of the company solely for the purpose of seeking comments from the public. However, it should be clearly understood that due to the dynamic changes in the market environment, the content covered in this article may have limitations and it should not be construed to make any investment decision.